Scott M. Giacobello

Insider Reports History

Location
Cambridge, United Kingdom
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Giacobello:

Company Role Class Num Shares Value Price $ Report Date Ownership
Whitehawk Therapeutics, Inc. CHIEF FINANCIAL OFFICER Restricted Stock Units 473,902 $1,137,365 $2.40 01 Apr 2025 Direct
Aadi Bioscience, Inc. CHIEF FINANCIAL OFFICER Common Stock 23,944 $56,268 $2.35 03 Mar 2025 Direct
Whitehawk Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (right to buy) 473,902 01 Apr 2025 Direct
GW PHARMACEUTICALS PLC Chief Financial Officer Ordinary Shares 0 05 May 2021 Direct
GW PHARMACEUTICALS PLC Chief Financial Officer Share Options 0 05 May 2021 Direct

Insider Reports Filed by Scott M. Giacobello

Symbol Company Period Transactions Value $ Form Type Role Filing Time
WHWK Whitehawk Therapeutics, Inc. 01 Apr 2025 2 $0 4 CHIEF FINANCIAL OFFICER 03 Apr 2025, 19:23
WHWK Aadi Bioscience, Inc. 01 Mar 2025 3 -$6,594 4 CHIEF FINANCIAL OFFICER 03 Mar 2025, 20:38
WHWK Aadi Bioscience, Inc. 01 Mar 2024 3 $0 4 CHIEF FINANCIAL OFFICER 04 Mar 2024, 19:12
WHWK Aadi Bioscience, Inc. 03 Apr 2023 1 $0 4 CFO, Interim CEO & President 04 Apr 2023, 16:07
WHWK Aadi Bioscience, Inc. 01 Mar 2023 1 $0 4 Chief Financial Officer 02 Mar 2023, 15:08
WHWK Aadi Bioscience, Inc. 26 Sep 2022 1 +$250,000 4 Chief Financial Officer 27 Sep 2022, 19:17
WHWK Aadi Bioscience, Inc. 01 Apr 2022 1 $0 4 Chief Financial Officer 05 Apr 2022, 20:17
WHWK Aadi Bioscience, Inc. 28 Nov 2021 0 $0 3 Chief Financial Officer 29 Nov 2021, 15:10
/report/000089924321018661-giacobello-scott-m-2021-05-05 GW PHARMACEUTICALS PLC 05 May 2021 12 $0 4 Chief Financial Officer 07 May 2021, 16:15